These findings suggest that CIT + leucine taken alongside exercise may improve body composition and activity levels, potentially reducing sarcopenia and frailty risk in older women (47)
2023, NEJM) showed 20 percent reduction in major adverse cardiovascular events, opened a separate pathway on most UHC plans
Rahmani F, Ghezzi L, Tosti V, Liu J, Song S-K, Wu AT, Rajamanickam J, Obert KA, Benzinger TLS, Mittendorfer B, Piccio L, Raji CA (2023) Twelve weeks of intermittent caloric restriction diet mitigates neuroinflammation in midlife individuals with multiple sclerosis: a pilot study with implications for prevention of Alzheimers disease
FDA "Compounding and the FDA: Questions and Answers" (regulatory status of compounded medications): fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers FDA September 2025 telehealth warning letters (58 firms) + March 2026 additional letters (30 firms) on misleading compounded GLP-1 marketing: fda.gov warning letters database FTC NextMed final order (2025) on telehealth advertising compliance and fabricated reviews: ftc.gov/legal-library/browse/cases-proceedings New England Journal of Medicine STEP 1 (Wilding et al., 2021)
:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
